Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Rating) major shareholder Bros. Advisors Lp Baker bought 19,000 shares of the firm’s stock in a transaction on Monday, May 16th. The shares were bought at an average cost of $5.83 per share, for a total transaction of $110,770.00. Following the purchase, the insider now owns 4,374,493 shares of […]
Kodiak Sciences Inc. (NASDAQ:KOD – Get Rating) Director Bros. Advisors Lp Baker purchased 223,766 shares of Kodiak Sciences stock in a transaction dated Wednesday, May 18th. The stock was bought at an average price of $5.97 per share, for a total transaction of $1,335,883.02. Following the completion of the transaction, the director now directly owns […]
Kodiak Sciences (NASDAQ:KOD – Get Rating) had its price objective reduced by analysts at Morgan Stanley to $10.00 in a report released on Tuesday, Stock Target Advisor reports. The firm currently has an “equal weight” rating on the stock. Morgan Stanley’s price objective would indicate a potential upside of 69.49% from the stock’s current price. […]
Incyte (NASDAQ:INCY – Get Rating) had its price objective raised by Stifel Nicolaus from $75.00 to $77.00 in a research note published on Tuesday, The Fly reports. Several other analysts have also issued reports on INCY. StockNews.com started coverage on shares of Incyte in a research report on Thursday, March 31st. They set a strong-buy […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.